Kymera Therapeutics was recently approved to receive venture capital on 10/30/2017 (Series A $3,000,0000). This may be a great time to reach out and discuss ways on how they can spend their money. An Up-Sell report has been prepared for Kymera Therapeutics here: http://bit.ly/2BhgYEh